Allergic rhinitis is a common condition caused by inflammation of nasal mucosa. The study was performed to gain information on this inflammation, including effect of intranasal corticosteroid treatment hereupon and potential influence on the lower airways, ie asthma. The study was randomised, placebo-controlled double-blind in patients, monoallergic to grasspollen, presenting symptoms of rhinitis and asthma during season. Treatment,ie intranasal corticosteroid or placebo, were given four weeks. After two weeks of treatment intranasal allergen challenge was performed. Measurements were performed during the full study period. The study was performed out of pollen season.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Enrollment
24
Department of Respiratory Diseases, Aarhus University Hospital
Aarhus, Denmark
Serum Eosinophil Cationic Protein (ECP)
Time frame: 1 month
Serum Eosinophil Peroxidase (EPO)
Time frame: 1 month
Nasal lavage Eosinophil Cationic Protein (ECP)
Time frame: 1 month
Nasal lavage Eosinophil Peroxidase (EPO)
Time frame: 1 month
Blood Eosinophils
Time frame: 1 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.